Adial Pharmaceuticals, Inc. - ADIL Net Assets per Single Share

Public company logo of Adial (ADIL)

Adial Pharmaceuticals specializes in alcohol dependence therapy, offering the drug AD04 for individuals with a genetic predisposition. The growth rate of the stock's book value demonstrates capital protection dynamics, where -14.55 reflects the latest metric value. A strong team of scientists and clinical experts ensures stable R&D development. The current lack of profit is attributed to the product development stage.

Adial (ADIL) Equity per Share: for the period 07/04/2022 - 10/27/2026

Summary analytical data breakdowns for Adial Pharmaceuticals Inc. (ADIL)

- price and consensus price forecast:
Stock Price Adial|ADIL - Analyst Median Target
- market capitalization data:
Market Value Adial Pharmaceuticals, Inc.|ADIL - Total Company Value
- book capitalization data:
Net Assets per Single Share Adial Pharmaceuticals|ADIL - Accounting Capitalization|Market Capitalization to Book Value Ratio adialpharma.com|ADIL - Company Total Assets
- debt and liquidity data:
Debt to Equity Adial Pharmaceuticals|ADIL - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Adial|ADIL - Company Total Debt|Debt to Book Capitalization Ratio Adial Pharmaceuticals, Inc.
Fundamental company valuation:adialpharma.com, ADIL
Signature product of Adial Pharmaceuticals Inc.

For Adial Pharmaceuticals (ADIL), which is developing an addiction therapy ecosystem with the drug AD04, this metric reflects the net equity value per share after deducting all liabilities. An analysis of the average book value per share allows for an assessment of the company's actual asset base, where capital dynamics serve as an indicator of the business's financial stability during periods of market consolidation.

Competitor analysis

Book Value per Share INDV (Indivior Group)|COLL: Net Assets per Share|Cronos Group Inc. (CRON) - Net Assets per Single Share|CGC (canopygrowth.com) - Net Assets per Single Share|Net Assets per Single Share High Tide (HITI)|Equity per Share Aurora|Book Value per Share ACHV|Book Value per Share SKYE (Skye Bioscience Inc.)|Net Assets per Single Share Anebulo Pharmaceuticals|Accounting Value of a Share InterCure Ltd INCR|NTRB: Book Value per Share|NSRX: Accounting Value per Share|Net Assets per Single Share IGC|Net Asset Value per Share MIRA Pharmaceuticals, Inc.|FLGC - Accounting Value per Share|Accounting Value of a Share IMC|ARTL - Book Value per Share|Share Book Value ensysce.com (ENSC)|Book Value per Share TTNP (Titan Pharmaceuticals, Inc.)|Greenlane Corp - Book Value per Share|Net Assets per Single Share InMed Pharmaceuticals (INM)|AKAN: Accounting Value of a Share|ENVB (Enveric Biosciences, Inc.) - Net Assets per Single Share|Bright Green Corporation (BGXX) - Accounting Value per Share|HPCO (Hempacco Co., Inc.) - Book Value per Share